W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® ILIAC BRANCH ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Catalog Number CEB231410A |
Device Problem
Patient Device Interaction Problem (4001)
|
Event Date 03/27/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
H6: code c19 - the review of the manufacturing paperwork verified that this lot met all pre-release specifications h6: code d12 ¿ according to the gore® excluder® iliac branch endoprosthesis instructions for use, adverse events with may occur and/or require intervention including, but not limited to, endoleak w.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
On (b)(6) 2021, the patient was treated for an abdominal aortic aneurysm.The physician implanted a competitor's device, along with a gore® excluder® iliac branch endoprosthesis branch component ceb231410a, and two gore® excluder® iliac branch endoprosthesis internal iliac components, hgb161407a and hgb161207a.The patient tolerated the procedure.On 27-mar-2024, a type ib endoleak was noted from the competitor's device in the left limb, and a gore® excluder® iliac branch endoprosthesis branch component 231410a was implanted.The physician stated that the endoleak was due to competitor device not being well apposed.In addition, the competitor device in the right limb had migrated proximally, and was no longer inside the gore ceb, creating a type iii endoleak.A competitor's device was placed inside the gore device and sealed the endoleak.The patient tolerated the procedure.
|
|
Manufacturer Narrative
|
Added g3/g4, h1/h2, and h6.H6: investigation conclusions: d1001 updated to d1101: according to the gore® excluder® iliac branch endoprosthesis instructions for use, adverse events that may occur and/or require intervention include, but are not limited to, endoleak: improper component placement, component migration.Read all instructions carefully.Failure to properly follow the instructions, warnings, and precautions may lead to serious surgical consequences or injury to the patient.The safety and effectiveness of the gore® excluder® iliac branch endoprosthesis have not been evaluated in the following patient populations: - leaking: pending rupture or ruptured aneurysms - pseudoaneurysms resulting from previous graft placement - revision of previously placed stent-grafts.
|
|
Search Alerts/Recalls
|
|
|